Plain-English translation of NCT07073963 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Fatigue is a common and serious problem for people with sarcoidosis, and there are currently no approved medications to treat it. This study is testing whether mindfulness-based stress reduction (MBSR)—a structured program of guided relaxation and mindfulness practices—can help reduce fatigue and improve mental health. Researchers are comparing this approach to a traditional support group to see which helps more.
Many people with sarcoidosis struggle with debilitating fatigue that affects their quality of life, but there are no proven medical treatments available. Previous research has shown that mindfulness practices may help, so this study is designed to formally test whether this approach works and could become a helpful option for patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the mindfulness program or a support group. If you join the mindfulness program, you'll attend 8 weekly virtual sessions with a trained instructor where you'll learn and practice relaxation techniques, and you'll keep a brief diary of your practice at home. If you're in the support group, you'll join an existing monthly virtual sarcoidosis group with educational talks and peer discussion. Either way, you'll complete brief online surveys about your fatigue, mood, and quality of life at the start, after 8 weeks, and again at 5 months.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States